Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 1
1(50.0%)
N/A
1(50.0%)
2Total
Phase 1(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05616559Recruiting

Precision Medicine in the Depression Treatment

Role: collaborator

NCT03795688Completed

The Role of Sex Steroids and Serotonin Brain Dynamics in Perinatal Mental Health

Role: collaborator

NCT02869035Phase 1Completed

Treatment Outcome in Major Depressive Disorder

Role: collaborator

NCT02661789Not ApplicableCompleted

Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression

Role: collaborator

All 4 trials loaded